|
|
||||||||


*
Istituto di Morfologia Umana Normale, Chieti, Italy;
Cattedra di Neonatologia, Università degli Studi "G. DAnnunzio," Chieti, Italy;
Istituto di Anatomia Umana Normale, Università di Bologna, Bologna, Italy;
§
Dipartimento di Scienze Biomediche e Biotecnologie, Sezione di Anatomia Umana, Università di Brescia, Brescia, Italy; and
¶
Laboratory of Immunobiology, Division of Monoclonal Antibodies, Center for Biologics Evaluation and Research, Bethesda, MD 20852
Adult and neonatal immunocompetent cells exhibit important
functional distinctions, including differences in cytokine production
and susceptibility to tolerance induction. We have investigated the
molecular features that characterize the immune response of cord
blood-derived T lymphocytes compared with that of adult T lymphocytes.
Our findings demonstrate that phospholipase C (PLC) isozymes, which
play a pivotal role in the control of protein kinase C activation and
Ca2+ mobilization, are differently expressed in cord and
adult T lymphocytes. PLCß1 and
1 are expressed at higher levels in
cord T cells, while PLCß2 and
1 expression is higher in adult T
lymphocytes. PLC
2 and
2 appear to be equally expressed in both
cell types. In addition, a functional defect in PLC activation via CD3
ligation or pervanadate treatment, stimuli that activate tyrosine
kinases, was observed in cord blood T cells, whereas treatment with
aluminum tetrafluoride (AlF4-), a G protein
activator, demonstrated a similar degree of PLC activation in cord and
adult T cells. The impaired PLC activation of cord blood-derived T
cells was associated with a a very low expression of the Src kinase,
Lck, along with a reduced level of ZAP70. No mitogenic response to CD3
ligation was observed in cord T cells. However, no signaling defect was
apparent downstream of PLC activation, as demonstrated by the mitogenic
response of cord T cells to the pharmacologic activation of protein
kinase C and Ca2+ by treatment with PMA and ionomycin.
Thus, neonatal cord blood-derived T cells show a signaling immaturity
associated with inadequate PLC
activation and decreased Lck
expression.
This article has been cited by other articles:
![]() |
Y. J. Ha, Y.-C. Mun, C.-M. Seong, and J. R. Lee Characterization of phenotypically distinct B-cell subsets and receptor-stimulated mitogen-activated protein kinase activation in human cord blood B cells J. Leukoc. Biol., December 1, 2008; 84(6): 1557 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Goldberg, N. Luknar-Gabor, G. Zadik-Mnuhin, P. Koch, J. Tovbin, and Y. Katz Synergy between LPS and immobilized anti-human CD3{epsilon} mAb for activation of cord blood CD3+ T cells Int. Immunol., January 1, 2007; 19(1): 99 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Randolph The Neonatal Adaptive Immune System NeoReviews, October 1, 2005; 6(10): e454 - e462. [Full Text] [PDF] |
||||
![]() |
S. Kobayashi, K. Ohnuma, M. Uchiyama, K. Iino, S. Iwata, N. H. Dang, and C. Morimoto Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation Blood, February 1, 2004; 103(3): 1002 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jullien, R. Q. Cron, K. Dabbagh, A. Cleary, L. Chen, P. Tran, P. Stepick-Biek, and D. B. Lewis Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation Int. Immunol., December 1, 2003; 15(12): 1461 - 1472. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Canto, J. L. Rodriguez-Sanchez, and S. Vidal Distinctive response of naive lymphocytes from cord blood to primary activation via TCR J. Leukoc. Biol., December 1, 2003; 74(6): 998 - 1007. [Abstract] [Full Text] |
||||
![]() |
M. Marchisio, A. Di Baldassarre, D. Angelucci, E. Caramelli, A. Cataldi, S. Castorina, A. Antonucci, L. Di Giovannantonio, C. Schiavone, R. Di Biagio, et al. Phospholipase C {delta}2 Expression Characterizes the Neoplastic Transformation of the Human Gastric Mucosa Am. J. Pathol., September 1, 2001; 159(3): 803 - 808. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |